Greenwood Capital Associates LLC Lowers Position in Apyx Medical Co. (NASDAQ:APYX)

Greenwood Capital Associates LLC lessened its stake in Apyx Medical Co. (NASDAQ:APYX - Free Report) by 89.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 23,671 shares of the company's stock after selling 208,087 shares during the period. Greenwood Capital Associates LLC owned about 0.06% of Apyx Medical worth $32,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. Citadel Advisors LLC boosted its position in shares of Apyx Medical by 130.6% during the 4th quarter. Citadel Advisors LLC now owns 66,355 shares of the company's stock valued at $105,000 after purchasing an additional 37,582 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of Apyx Medical during the 4th quarter valued at about $134,000. Northern Trust Corp boosted its position in shares of Apyx Medical by 27.9% during the 4th quarter. Northern Trust Corp now owns 132,251 shares of the company's stock valued at $209,000 after purchasing an additional 28,865 shares in the last quarter. Kingsview Wealth Management LLC boosted its position in shares of Apyx Medical by 8.7% during the 4th quarter. Kingsview Wealth Management LLC now owns 135,245 shares of the company's stock valued at $214,000 after purchasing an additional 10,800 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Apyx Medical by 7.5% during the 4th quarter. Geode Capital Management LLC now owns 352,809 shares of the company's stock valued at $558,000 after purchasing an additional 24,596 shares in the last quarter. Institutional investors own 55.33% of the company's stock.

Apyx Medical Trading Up 6.3%

Shares of Apyx Medical stock traded up $0.11 on Monday, hitting $1.86. 61,584 shares of the company's stock traded hands, compared to its average volume of 78,796. Apyx Medical Co. has a one year low of $0.76 and a one year high of $2.00. The company has a debt-to-equity ratio of 3.03, a current ratio of 5.46 and a quick ratio of 4.52. The company has a fifty day moving average of $1.32 and a two-hundred day moving average of $1.39. The company has a market capitalization of $70.30 million, a price-to-earnings ratio of -2.24 and a beta of 1.21.

Apyx Medical (NASDAQ:APYX - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.10) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.03. Apyx Medical had a negative return on equity of 137.98% and a negative net margin of 58.59%. The business had revenue of $9.43 million for the quarter, compared to the consensus estimate of $9.39 million. As a group, sell-side analysts expect that Apyx Medical Co. will post -0.68 earnings per share for the current year.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.